Q20 Q21 Q22 Q23 Q24 Q25 Q26 Q27 Q28
Conditions
Interventions
Group 1: Meassured longitudinally at each oupatient clinical appointment:
-Anamnesis (medication, heart defect, surgeries, cardiac catheter interventions, findings of cardio pulmonary exercise test)
Sponsors
Lehrstuhl für Präventive Pädiatrie der Technischen Universität München
Eligibility
Sex/Gender
All
Age
6 Years to 17 Years
Inclusion criteria
Inclusion criteria: Patients with congenital heart defects who are recruited in the Clinic for Congenital Heart Defects and Pediatric Cardiology of the German Heart Center Munich.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Do children and adolescents with a congenital heart defect already have an increased cardiovascular risk (high blood pressure, increased vascular stiffness, increased visceral fat) as well as motoric deficits compared to cardiac healthy of the same age? | — |
Secondary
| Measure | Time frame |
|---|---|
| Are there gender differences? Are there differences in the type of heart defect and the severity of the heart defect? Are there correlations between cardiovascular risk, sports motor skills and quality of life? How does the COVID-19 pandemic affect the health-related quality of life of children and young people with congenital heart defects? | — |
Countries
Germany
Contacts
Public ContactJan Müller
Lehrstuhl für Präventive Pädiatrie der Technischen Universität München
Outcome results
None listed